When was Amgen founded?

Amgen was founded in 1980 and raised its 1st funding round 30 years after it was founded.

Where is Amgen located?

Amgen is headquartered in Thousand Oaks, United States. It is registered at Thousand Oaks, California.

How many employees does Amgen have?

As of Jul 31, 2026, the latest employee count at Amgen is 41377.

Is Amgen a funded company?

Amgen is a funded company, having raised an undisclosed amount across 2 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Jan 01, 2010.

When was the latest funding round of Amgen?

Amgen's latest funding was a $***** Post IPO round on Mar 12, 2012, with participation from 0 investor.

What is the annual revenue of Amgen?

Annual revenue of Amgen is more than $1B as on Dec 31, 2025

Where does Amgen rank among its competitors?

Amgen ranks 3rd amongst 1826 active competitors, of which 95 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was AstraZeneca, which secured $6.05M in Jul, 2025.

Who are the top competitors of Amgen?

Amgen's top competitors include AbbVie, Gilead and AstraZeneca. Among them, AstraZeneca secured the most recent funding round in July, 2025.

Amgen - 2026 Company Profile, Team, Funding, Competitors & Financials

Amgen is a public company based in Thousand Oaks (United States), founded in 1980 by Kate Gavljak Mchem Ba. It operates as a Developer of pharmaceutical products for treating multiple diseases. Amgen has raised an undisclosed amount in funding. The company has 1826 active competitors, including 95 funded and 203 that have exited. Its top competitors include companies like AbbVie, Gilead and AstraZeneca.

Company Details

Developer of pharmaceutical products for treating multiple diseases. It manufactures and market human therapeutics based on advances in cellular and molecular biology. It markets human therapeutic products in the areas of hematology, oncology, and inflammation. In 2022, the company recorded annual revenues of $26.32B and a net profit of $6.55B.

Website: www.amgen.com/
Social
Email ID: *****@amgen.com
Phone Number: +1 **********
Registered Address: Thousand Oaks, California

Key Metrics

Founded Year

1980

Location

Thousand Oaks, United States

Stage

Public

Latest Funding Round

Post IPO, Mar 12, 2012, $*****

Investors

Digital Pharma Lab & 12 more

Ranked

3^rd among 1826 active competitors

Annual Revenue

$1B+ as on Dec 31, 2025

Employee Count

41,377 as on Jul 31, 2026

Investment & Acquisitions

Ember LifeSciences & 93 more

Similar Companies

AbbVie & 1853 more

Exit Details

Public

View Amgen's full profile

Amgen is associated with 10 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Com8 s.r.o. CIN: 03506444 , Czech Republic, Active	Oct 22, 2014	-	-
AMGEN D.O.O. CIN: 18002446709 , Croatia, Active	Jul 15, 2013	€1M - €10M (As on Dec 31, 2024)	-
Amgen Inc. CIN: 953540776 , United States, Active	Dec 26, 999	-	14965 (As on Dec 31, 2024)	-
LAMGen s.r.o. CIN: 28331117 , Czech Republic, Active	Mar 10, 2009	-	-
Amgen Inc. CIN: 10208272 , United States, Active	Sep 11, 2022	-	-	-
Amgen CIN: - , Belgium, Active		-	-	-
AMGA Finance Solution s.r.o. CIN: 03516741 , Czech Republic, Active	Oct 24, 2014	-	-
AMGEN TECHNOLOGY PRIVATE LIMITED CIN: U62099MH2007FTC168485 , India, Active	Mar 08, 2007	₹100 - ₹500 Cr (As on Mar 31, 2025)	22 (As on Mar 31, 2024)
Amgen Inc CIN: 318154 , United States, Active	Oct 30, 1986	$1B+ (As on Dec 31, 2025)	-	-
AMGEN MANUFACTURING, LIMITED CIN: 980210484 , United States, Active	Dec 26, 999	-	2589 (As on Dec 31, 2024)	-

Amgen got listed on Oct 01, 1984.

Click here to take a look at Amgen's IPO in detail

Amgen has raised funding over 2 rounds. Its first funding round was on Jan 01, 2010. Amgen has 13 institutional investors.

Here is the list of recent funding rounds of Amgen:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 12, 2012	6617203	Post IPO	2598701	9455844	2490040	2592017
Jan 01, 2010	8004156	Grant (prize money)	2176664	7363674	3629284	Europa

Access funding benchmarks and valuations. Sign up today!

View details of Amgen's funding rounds and investors

The founders of Amgen is Kate Gavljak Mchem Ba. Robert Bradway is the CEO of Amgen.

Here are the details of Amgen's key team members:

Kate Gavljak Mchem Ba: Senior Product Manager, Head & Founder Patient Innovation Centre of Amgen.

View details of Amgen's Founder profiles and Board Members

Amgen's employee count trend

Amgen has 41,377 employees as of Jul 26. Here is Amgen's employee count trend over the years:

Uncover Amgen's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Amgen include AbbVie, Gilead and AstraZeneca. Here is the list of Top 10 competitors of Amgen, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	AbbVie 2012, Chicago (United States), Public	Research-based biopharmaceutical company	$14.7B	Berkshire Hathaway, Alcor Fund & 9 others	83/100
2nd	Gilead 1987, Foster City (United States), Acquired	Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others	-	Jindal ventures, Seaside Private Capital ... & 17 others	81/100
3rd	Amgen 1980, Thousand Oaks (United States), Public	Developer of pharmaceutical products for treating multiple diseases	-	Digital Pharma Lab, Amgen Business Development ... & 11 others	79/100
4th	AstraZeneca 1999, Cambridge (United Kingdom), Public	Developer of pharmaceutical medicines for oncology and various chronic diseases	-	Digital Pharma Lab, Columbia Capital & 13 others	76/100
5th	Lilly 1876, Indianapolis (United States), Public	Developer of traditional pharmaceutical medicines	-	Alcor Fund, Digital Pharma Lab & 11 others	75/100
6th	Johnson & Johnson 1886, New Brunswick (United States), Public	Manufacturer and supplier of beauty care products, medical devices, and pharmaceutical products	-	Western Technology Investment, Alcor Fund ... & 16 others	74/100
7th	Novartis 1996, Basel (Switzerland), Acquired	R&D focused on manufacturing of drugs for multiple therapeutic areas	-	Digital Pharma Lab, Atlas Venture & 9 others	71/100
8th	Roivant Sciences 2014, New York City (United States), Public	Developer of therapeutics to treat neurology, oncology, rare, and endocrinology based diseases	$1.3B	SoftBank Vision Fund, NovaQuest Capital Management ... & 8 others	70/100
9th	Roche 1896, Basel (Switzerland), Public	Developer of pharmaceuticals and diagnostics kits	-	Gilde Healthcare, Triodos Investment Management ... & 11 others	70/100
10th	Genentech 1976, San Francisco (United States), Acquired	R&D company focused on manufacturing drugs for multiple therapeutic areas	$72.5M	Ignite 500, The Column Group & 4 others	69/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Amgen's competitors? Click here to see the top ones

Amgen has made 69 investments in companies including Ember LifeSciences and Cartography Biosciences. Amgen has also acquired 25 companies including Dark Blue Therapeutics and Horizon Therapeutics.

Here is the list of investments & acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
May 26, 2026	Investments	Ember LifeSciences	2022	Westlake Village (United States)
Jan 06, 2026	Acquisition	Dark Blue Therapeutics	2020	Oxford (United Kingdom)
Oct 02, 2025	Investments	Cartography Biosciences	2020	Foster City (United States)